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Abstract
Meeting patients' nutritional requirements and preventing malnutrition is a challenge following
major surgical procedures. The role of ghrelin in nutritional recovery after non-gastrointestinal
major surgery is unknown. We used coronary artery bypass grafting (CABG) as an example of
anticipated good recovery post major surgery.
Seventeen patients undergoing CABG (mean ± SEM: 70.1 ± 2.2 yrs, BMI 29.1 ± 1.4 kg/m2, 15 male)
underwent fasting and postprandial (45 mins after standard test breakfast) blood sampling pre-
operatively (day 0), post-operatively (day 6) and at follow-up (day 40). Changes in food intake,
biochemical and anthropometric markers of nutritional status were recorded. A comparison was
made to 17 matched healthy controls (70.6 ± 2.3 yrs, BMI 28.4 ± 1.3 kg/m2).
We observed significantly increased post-operative and follow-up fasting ghrelin concentrations
compared with pre-operatively (pre-op. 402 ± 42 pmol/L vs post-op. 642 ± 97 pmol/L vs follow-
up 603 ± 94 pmol/L) (ANOVA p < 0.05). Significantly exaggerated postprandial suppression of
ghrelin was seen postoperatively and continued until follow-up (∆ pre-op. 10 ± 51 pmol/L vs ∆
post-op. -152 ± 43 pmol/L vs ∆ follow-up -159 ± 65 pmol/L, p < 0.05). This was associated with a
50% reduction in food intake {post-op. 4.5 ± 0.5 MJ/D (1076 ± 120 kcal/D) compared with
estimated requirements 9.9 ± 0.5 MJ/D (2366 ± 120 kcal/D)}, leading to a 4% weight loss and a 5%
reduction in muscle arm circumference loss over length of follow up.
Our data support the hypothesis that prolonged changes in fasting and postprandial plasma ghrelin
concentrations are associated with impaired nutritional recovery after CABG. These findings
reinforce the need to investigate ghrelin in other patients groups undergoing major surgery.
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Findings
Malnutrition remains a largely unrecognised problem in
hospitalised patients [1]. Moreover delayed nutritional
recovery after routine surgery is also under-appreciated.
Peptide hormones released from the gut have been
reported to affect appetite and may play a role in the
altered food consumption of patients [2]. Ghrelin, a 28
amino acid peptide, is produced by the stomach, regulates
the initiation of feeding, and its level is highest in the fast-
ing state, falling within one hour of a meal [3].
The dynamic response of this hormone in patients who
undergo major surgery, for example CABG is unknown. In
this study we hypothesised that the driving mechanism
for decreased energy intake and weight loss in surgical
patients may be abnormal ghrelin concentrations.
We undertook a prospective clinical cohort study in the
Department of Cardiothoracic Surgery, Hammersmith
Hospital, London UK over a 6 month period. Local
research ethics committee approval was obtained for the
enrolment of both patients and control subjects (05/
Q0406/16); written informed consent was also obtained.
The study was performed in accordance with the Helsinki
Declaration of 1975 as revised in 1983. Inclusion criteria
were patients aged greater than 50 years who were sched-
uled for an elective CABG procedure. Exclusion criteria
included those requiring urgent revascularisation,
advanced renal failure, heart failure and severe chronic
obstructive pulmonary disease (COPD) with weight loss.
Healthy control volunteers matched for age and body
mass index (BMI) were recruited by local advertisement.
All CABG patients underwent fasting and postprandial
(45 mins after the start of standard test breakfast) blood
sampling pre-operatively (day 0), post-operatively (day 6)
and at follow up (day 40). The vulnerability of CABG
patients, blood loss postoperatively, and ethical issues
restricted us to just one postprandial blood sample. The
45 mins time point was used as this has previously been
shown to represent the marked nadir in ghrelin [4-6].
The standard test breakfast consisted of 2.76 MJ (660 kcal)
(17% protein, 54% carbohydrate and 29% fat) (Ensure
Plus, Abbott Nutrition). 15/17 consumed all of the test
breakfast on each occasion, 2 patients consumed 75%.
Control subjects visited the hospital on 3 separate occa-
sions to undergo fasting blood samples. On the third visit
they also consumed a test breakfast as above.
Concentrations of plasma ghrelin immunoreactivity were
measured using an established in-house radioimmu-
noassay as described previously [5]. The assay detected
changes of 25 pmol/l of plasma ghrelin with a 95% confi-
dence limit. The intra-and interassay coefficient of varia-
tion were 5.5 and 10.1 %, respectively[6]. Appetite, food
intake, anthropometric and biochemical indices were col-
lected. Patients and controls were asked to complete a vis-
ual analogue scale (VAS) for appetite before and 45 min
following each test meal [7]. A 3-day dietary intake was
recorded post operation (between days 4–6) and prior to
the follow up visit. Estimated energy requirements were
used to compare the total energy intake of patients in hos-
pital and at follow-up visits with their estimated nutri-
tional requirements [8,9]. Healthy control subjects also
completed a 3-day dietary record. Food intake data were
analysed using Dietplan 6 (Forrest Hill Software Ltd, Sus-
sex, UK). Mid arm circumference (MAC) and body weight
were assessed pre-operatively, post-operatively, and at fol-
low-up [10,11]. Albumin, protein, C-reactive protein
(CRP), and haemoglobin concentrations were extracted
from the patient records.
A power calculation based on a previous study using a
power of 80% and alpha 5% suggested a sample size of 7
patients matched to 7 controls would be sufficient to
show significant changes between patients and control
subjects (mean difference 414 pmol/l and standard devi-
ation 248). The data were analysed using SPSS 13.0 for
windows (SPSS Science, Apache Software Foundation,
Chicago, IL, USA).
All data were checked for normality and presented as
mean plus minus standard error of the mean (SEM). Sim-
ple or repeated measures analysis of variance (ANOVA)
was used for multiple comparison testing; where appro-
priate, post hoc testing was performed using Dunnett and
Newmans-Keuls's test respectively. In all cases, p < 0.05
was considered to be statistically significant.
Seventeen CABG patients completed the study (mean ±
SEM: age 70.1 ± 2.2 yrs, BMI 29.1 ± 1.4 kg/m2, 15 male).
Patients were compared with matched control volunteers
(70.6 ± 2.3 yrs, BMI 28.4 ± 1.3 kg/m2, 15 male). There was
no difference in fasting plasma ghrelin concentrations
between CABG pre-operatively and controls (Figure 1).
We observed an increase in post-operative fasting ghrelin
concentration compared with pre-operatively. Our data
also revealed an exaggerated postprandial suppression of
ghrelin concentrations postoperatively and at follow-up,
but not pre-operatively nor in control subjects (Figure 1).
Although VAS indicated patients postoperatively reported
a higher fasting hunger rating than controls (postop. 38 ±
5 mm vs follow-up 45 ± 8 mm vs controls 23 ± 3 mm P =
0.02 and p = 0.008 respectively), they had greater post-
prandial appetite suppression compared to controls.
Mean daily energy intake on day 6 was 50% lower in
CABG patients compared to their estimated energyNutrition & Metabolism 2007, 4:20 http://www.nutritionandmetabolism.com/content/4/1/20
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requirement {4.5 ± 0.5 MJ/D (1076 ± 120 kcal/D) vs
requirements 9.9 ± 0.5 MJ/D (2366 ± 120 kcal/D) p <
0.001)} and compared with healthy control subjects {4.5
± 0.5 MJ/D (1076 ± 120 kcal/D) vs 10.21 ± 0.92 MJ/D
(2440 ± 220 kcal/D) p < 0.001}. At follow-up patients still
did not meet all of their energy requirements; they had a
1.73 MJ (413 kcal) lower daily energy intake than their
estimated energy requirements, or 2.17 MJ (519 kcal)
lower daily energy intake than control subjects. There was
a 4% weight loss and a 5% decrease in MAC from pre-
operatively to follow-up, (p < 0.005 and p < 0.008 respec-
tively). Post-operatively patients had lower albumin, total
protein, and haemoglobin and also higher CRP compared
with pre-operatively (p < 0.0001). This returned to normal
on day 40 at follow-up visit (data not shown).
This is the first report to observe a describe in fasting
plasma ghrelin concentrations post-operatively and exag-
gerated ghrelin suppression following a test meal in CABG
patients, despite pre-prandial appetite being preserved.
Exogenous ghrelin administration has been shown to
increase hunger and food intake [12]. Thus our data are
consistent with an increase initial motivation for food
postoperatively that was supported by the VAS data. Our
data reveal an exaggerated postprandial suppression of
ghrelin postoperatively, and at follow-up compared to
pre-operatively, which would be expected to be associated
with a reduced food intake [5]. The exaggerated ghrelin
suppression may be responsible for a reduced drive to eat
during meal times, or early satiety. Although ghrelin can
be considered as a participant in food intake and body-
weight regulation, its role in acute illness is not yet fully
understood. It is uncertain whether older individuals with
significant underlying medical problems would also
adapt appropriately to acute weight loss [13-15].
Results from various recent studies in healthy subjects
propose that ghrelin may play a role in appetite regula-
tion. Cummings et al. studied the pattern of plasma ghre-
lin concentrations over 24 hours. Levels rose by an
average of 78% 1–2 h before the onset of each meal, and
fell to nadir levels within 1 h after food was first con-
sumed, suggesting that ghrelin concentrations decline
quickly after each meal, returning to pre-meal concentra-
tions before the next meal is initiated[3]. Intravenous
infusions of ghrelin in healthy human volunteers were
also shown to enhance subjectively-rated appetite and to
increase energy intake [12]. Furthermore, diurnal rhythms
in ghrelin concentrations before and after weight loss
were in accord with diurnal rhythms in appetite in
humans [16,17]. Test meal studies demonstrated post-
prandial ghrelin suppression is associated with a reduc-
tion in hunger in normal-weight subjects [5,18]. Recent
studies on ghrelin shed light on the possible role of this
hormone in acute illness. Alterations in ghrelin concentra-
tion may have a role to play in appetite and energy intake
in acute illness, thus contributing to hospital malnutrition
[2]. Previous studies have confirmed the role of ghrelin in
meal initiation [3,16]. Results from studies infusing ghre-
lin in cancer patients [19] and administering subcutane-
ous ghrelin in dialysis patients with mild to moderate
malnutrition [20] suggest ghrelin may be helpful to
increase appetite in cachectic or malnourished patients.
In the current study, an acute phase response to surgery
was observed during the whole stay. Acute phase response
proteins and cytokines release may have affected the gut
hormone concentrations. It is not fully understood how
changes in acute phase response proteins affect ghrelin
concentrations. Further research is required before any
dietary interventions, aiming to manipulate ghrelin
release can be recommended. It appears that ghrelin plays
different roles in several pathologies. Although ghrelin is
well-known as a hormone that is associated with negative
energy balance, further work in different patient groups
might further reveal the role of ghrelin on appetite and
food intake.
Particular areas requiring elucidation include the relation-
ship between inflammatory cytokines and gut hormone
activity and also the impact of medication, especially anti-
biotics which affect gut flora, and vasoactive drugs which
have an effect on blood flow and motility.
Fasting (light grey bars) and postprandial (dark grey bars)  plasma ghrelin concentrations (mean ± SEM) 45 minutes fol- lowing the start of a test meal in 17 coronary artery bypass  grafting patients (CABG) and matched controls, + p < 0.05  fasting postop versus fasting preop & controls, fasting follow- up versus fasting preop & controls Figure 1
Fasting (light grey bars) and postprandial (dark grey bars) 
plasma ghrelin concentrations (mean ± SEM) 45 minutes fol-
lowing the start of a test meal in 17 coronary artery bypass 
grafting patients (CABG) and matched controls, + p < 0.05 
fasting postop versus fasting preop & controls, fasting follow-
up versus fasting preop & controls ; * p < 0.05 ∆ change 
postop & follow-up versus preop & controls (ANOVA).Nutrition & Metabolism 2007, 4:20 http://www.nutritionandmetabolism.com/content/4/1/20
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Postprandial ghrelin suppression is a natural response to
eating [5], that appears exaggerated after major surgery. In
this study patients consumed only half of their energy
requirements in the immediate post operative period and
had a significant lower daily energy intake at follow-up.
Over the 40-day study period they lost 4% body weight
and had a 5% reduction in MAC.
Ghrelin, an acylated peptide, stimulates feeding and GH
secretion via interactions with the GH secretagogue type
1a receptor (GHS-R1a), the functionally active form of the
GHS-R. Ghrelin enhances feeding via the neuronal path-
ways of neuropeptide Y/AgRP and orexin, which act as
orexigenic peptides in the hypothalamus [21]. Central
des-acyl ghrelin may activate orexin-expressing neurons,
perhaps functioning in feeding regulation through inter-
actions with a target protein distinct from the GHS-R. It is
not fully understood how sickness following major surgi-
cal procedures affect ghrelin receptors and their functions.
Although the mechanism of ghrelin's orexigenic activity is
related to the neuropeptide Y (NPY) and agouti-related
protein (AgRP) pathways [21], the interaction of ghrelin
with other energy-regulating systems is unclear.
In spite of the methodological limitation and being
restricted to just one postprandial blood sample (45
mins), we observed an exaggerated ghrelin suppression
post-operatively and at follow-up; we might have
expected less ghrelin suppression in the CABG patients
due to their BMI (29 kg/m2) category [5].
Several previous studies have suggested that plasma ghre-
lin concentration is associated with the short term regula-
tion of appetite and nutritional status [3,5,12].  Recent
work by our group showed suppressed baseline concen-
trations of ghrelin during a 28 day period after admission
to intensive care [2]. It is possible that ghrelin, may partly
be involved in long term regulation of food intake in par-
allel with their short-term effects in conjunction with sev-
eral other neural, humeral, and psychological factors that
manage this complex process, so called "appetite". This
idea is lent support by Cummings et al., who have high-
lighted evidence indicating that ghrelin can be considered
as a participant in long-term body-weight regulation [22].
Although this is a first study to assess dynamic responses
of ghrelin on a small number of CABG patients, it raises
the intriguing possibility that appetite regulatory peptide
concentrations may be influenced by surgical procedures,
thus contributing to continuing reduced daily energy
intake during the recovery period. Further studies are
required to establish definitively the role of ghrelin and
other gut hormones in post-operative surgical patients.
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